Research Use Only. For Laboratory Research Only. Not for Human or Veterinary Consumption. Not evaluated by the FDA.
Knowledge center

NAD+ 1000mg

Nicotinamide adenine dinucleotide

Overview

Overview

NAD+ 1000mg is a laboratory-grade coenzyme supplied by BioNEx Peptides for in vitro and preclinical research. Each vial contains 1000 mg lyophilized peptide, ≥99% HPLC purity, third-party verified. Intended exclusively for qualified research professionals investigating longevity pathways. Not a drug, supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. For research use only — not for human or veterinary consumption.

Background

History

NAD+ 1000mg has been characterized in the peer-reviewed literature over multiple decades of investigation. This section aggregates published citations spanning its identification, structural characterization, and subsequent laboratory research programs. See the References section below for the full bibliography.

Chemistry

Mechanism of action

Sequence
Molecular Formula
C21H27N7O14P2
Molecular Weight
663.43
CAS Number
53-84-9
Appearance
Lyophilized white to off-white powder
Purity
≥99% (HPLC)
Literature

Published research

Preclinical

Animal studies

Clinical

Human studies

No human-subject citations catalogued for NAD+ 1000mg.

Synthesis

Current scientific understanding

Research-grade coenzyme, ≥99% HPLC purity, lyophilized. Research use only.

References

References

  1. Preclinical peptide research review, Peptides Research Review (2023)
FAQ

Frequently asked questions

Scientific disclaimer

This page aggregates published scientific literature and analytical information for laboratory research reference only. Content is not evaluated by the FDA and does not constitute medical advice, dosage guidance, treatment claims, or administration instructions. Compounds are supplied strictly for in-vitro laboratory research by qualified professionals.